Transcriptional activity of P-TEFb kinase in vivo requires the C- terminal domain of RNA polymerase II

Gene

Volumn 254, Issue 1-2, 2000, Pages 139-145

  Napolitano, Giuliana ^a   Majello, Barbara ^a   Licciardo, Paolo ^a   Giordano, Anonio ^b   Lania, Luigi ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Cdk; CTD phosphorylation; RNAPII; Transcription elongation

Indexed keywords

CCNK PROTEIN, HUMAN; CCNT1 PROTEIN, HUMAN; CDK8 PROTEIN, HUMAN; CDK9 PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 9; CYCLIN DEPENDENT KINASE ACTIVATING KINASE; CYCLIN-DEPENDENT KINASE-ACTIVATING KINASE; CYCLINE; PROTEIN SERINE THREONINE KINASE; RNA POLYMERASE II; CYCLIN T1; ELONGATION FACTOR; POSITIVE TRANSCRIPTION ELONGATION FACTOR B; POSITIVE TRANSCRIPTION ELONGATION FACTOR B KINASE; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; CELL LINE; CHEMISTRY; COMPARATIVE STUDY; GENETIC TRANSCRIPTION; HUMAN; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; CARBOXY TERMINAL SEQUENCE; ENZYME PHOSPHORYLATION; ENZYME SUBSTRATE; ENZYME SUBUNIT; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION;

BINDING SITES; CELL LINE; CYCLIN-DEPENDENT KINASE 9; CYCLIN-DEPENDENT KINASES; CYCLINS; HUMANS; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; RNA POLYMERASE II; TRANSCRIPTION, GENETIC;

EID: 0034702734     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-1119(00)00278-X     Document Type: Article

References (21)

1. Chun R.F., Jeang K.-T. Requirements for RNA polymerase II carboxy-terminal domain for activated transcription of human retroviruses human T-cell lymphotropic virus I and HIV-1. J. Biol. Chem. 271:1996;27 888-27 894.
2. Dahmus M.E. Reversible phosphorylation of the C-terminal domain of RNA polymerase II. J. Biol. Chem. 271:1996;19 009-19 012.
3. Edwards M.C., Wong C., Elledge S.J. Human cyclin K, a novel RNA polymerase II-associated cyclin possessing both carboxy-terminal domain kinase and Cdk-activating kinase activity. Mol. Cell. Biol. 18:1998;4291-4300.
4. Fu T.-J., Peng J., Lee G., Drice D.H., Flores O. Cyclin K functions as a CDK9 regulatory subunit and participates in RNA polymerase II transcription. J. Biol. Chem. 274:1999;34 527-34 530.
5. Garber M.E., Wei P., KewalRamani V.N., Mayall T.P., Herrmann C.H., Rice A.P., Littman D.R., Jones K.A. The interaction between HIV-1 Tat and human cyclin T1 requires zinc and a critical cysteine residue that is not conserved in the murine CycT1 protein. Genes Dev. 12:1998;3512-3527.
6. Gerber H.-P., Hagmann M., Seipel K., Georgiev O., West M.A.L., Litingtung Y., Schaffner W., Corden J.L. RNA polymerase II C-terminal domain required for enhancer-driven transcription. Nature. 374:1995;660-662.
7. Gold M.O., Rice A.P. Targeting of CDK8 to a promoter-proximal RNA element demonstrates catalysis-dependent activation of gene expression. Nucleic Acids Res. 26:1998;3784-3788.
8. Majello B., Napolitano G., De Luca P., Lania L. Recruitment of human TBP selectively activates RNA polymerase II TATA-dependent promoters. J. Biol. Chem. 273:1998;16 509-16 516.
9. Majello B., Napolitano G., Giordano A., Lania L. Transcriptional regulation by targeted recruitment of cyclin-dependent CDK9 kinase in vivo. Oncogene. 18:1999;4598-4605.
10. Marshall N.F., Price D.H. Purification of P-TEFb, a transcription factor required for the transition into productive elongation. J. Biol. Chem. 270:1995;12 335-12 338.
11. Napolitano G., Licciardo P., Gallo P., Majello B., Giordano A., Lania L. The CDK9-associated cyclins T1 and T2 exert opposite effects on HIV-1 Tat activity. AIDS. 13:1999;1453-1459.
12. Okamoto H., Sheline C., Corden J., Jones K., Peterlin B. Transactivation by human immunodeficiency virus Tat requires the C-terminal domain of RNA polymerase II. Proc. Natl. Acad. Sci. U. S. A. 93:1996;11 575-11 579.
13. Peng J., Zhu Y., Milton J.T., Price D.H. Identification of multiple cyclin subunits of human P-TEFb. Genes Dev. 12:1998;755-762.
14. Price D.H. P-TEFb, a cyclin-dependent kinase controlling elongation by RNA polymerase II. Mol. Cell. Biol. 20:2000;2629-2634.
15. Reines D., Conaway R.C., Conaway J.W. Mechanism and regulation of transcriptional elongation by RNA polymerase II. Curr. Opin. Cell. Biol. 11:1999;342-346.
16. Rickert P., Seghezzi W., Shanahan F., Lees E. Cyclin C/CDK8 is a novel CTD kinase associated with RNA polymerase II. Oncogene. 12:1996;2631-2640.
17. Serizawa H., Makela T.P., Conaway J.W., Conaway R.C., Weinberg R.A., Young R.A. Association of Cdk-activating kinase subunits with transcription factor TFIIH. Nature. 374:1995;280-282.
18. Wei P., Garber M.E., Fang S.M., Fischer W.H., Jones K.A. A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA. Cell. 92:1998;451-462.
19. Yang X., Herrmann C.H., Rice A.P. The human immunodeficiency virus Tat protein specifically associate with TAK in vivo and requires the carboxyl-terminal domain of RNA polymerase II for function. J. Virol. 70:1996;4576-4584.
20. Zhou Q., Chen D., Pierstorff E., Luo K. Transcription elongation factor P-TEFb mediates Tat activation of HIV-1 transcription at multiple stages. EMBO J. 17:1998;3681-3691.
21. Zhu Y., Pe'ery T., Peng J., Ramanathan Y., Marshall N., Marshall T., Amendt B., Mathews M.B., Price D.H. Transcription elongation factor P-TEFb is required for HIV-1 tat transactivation in vitro. Genes Dev. 11:1997;2622-2632.